Overview Papers News People Institutions Terms Social Categories
Abbr. Expansion Instances Papers News
NAFLD non-alcoholic fatty liver disease
This overview on hepatic effects of TH provides the basis for understanding the complex regulatory network and its translational potential with regards to currently discussed treatment options of non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) involving TH mimetics.
 10 8 2
BW body weight
The supply was calculated in relation to body weight (BW) in four treatments: 0% (control); 0.25, 0.50, and 1% of palm kernel cake, distributed in a completely randomized design.
 8 8 0
LT liver transplantation
BACKGROUND/PURPOSE This experimental study in rats aimed to investigate the impact of very early introduction (within 3 h) of everolimus (EVR) + reduced-tacrolimus (TAC) after partial liver transplantation (LT) on liver regeneration, rejection, and survival.
 6 6 0
VA Veterans Affairs
METHODS Using Veterans Affairs (VA) Informatics and Computing Infrastructure (VINCI), we identified a nationwide cohort of patients with an existing diagnosis of HCV or NAFLD with liver transient elastography (TE) testing from 2015 to 2019.
 6 2 4
HSCs hepatic stellate cells
Nevertheless, the effects of oxidized frying oil exposure on the activation of hepatic stellate cells (HSCs) and liver fibrosis are still unclear.
 6 4 2
EGFR epidermal growth factor receptor
Biophysical assay found that epidermal growth factor receptor (EGFR) on the hepatocyte surface was a direct binding and regulating target of MLT.
 6 6 0
NASH non-alcoholic steatohepatitis
This overview on hepatic effects of TH provides the basis for understanding the complex regulatory network and its translational potential with regards to currently discussed treatment options of non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) involving TH mimetics.
 5 4 1
PSM propensity score matching
The outcomes were compared between the two groups before and after the propensity score matching (PSM).
 5 5 0
GLP-1 glucagon-like peptide 1
Drug delivery systems such as lipid nanocapsules (LNCs) are a very versatile platform, easy to produce, and can induce the secretion of the native glucagon-like peptide 1 (GLP-1) when orally administered.
 4 2 2
CP crude protein
Fish meal was used as the sole protein source; five semi-purified diets were formulated with varying crude protein (CP) levels of 22.52%, 28.69%, 34.85%, 38.84%, 45.78% (CP1-CP5 diets).
 4 4 0